The overarching goal of the Education Core of the NYU-ADC is to facilitate recruitment into the ADC. To achieve this goal, and to translate information gained through research into improved diagnosis and care of elderly people with memory loss and dementia, the Education Core provides training and education about AD, MCI and changes in memory associated with normal aging to the elderly and their family members, health care professionals, social service providers and research scientists. Family counselors at the ADC disseminate information about memory loss and AD to caregivers and family members both formally, through lectures in the community and seminars at the NYU School of Medicine, and informally, through telephone and personal interactions. These activities directly and indirectly contribute to our ability to recruit new research subjects for the ADC and retain existing participants. Members of the professional staff of the NYU ADC lecture and provide resource information and consultation to staff members of health and social service providers in the community. Counselors mentor new AD support group leaders and social work interns. Publications and lectures have highlighted the unique contributions of the NYU-ADC to knowledge about AD both nationally and internationally. In addition, the Education Core facilitates training of health care professionals in the diagnosis and treatment of AD and exchange of information among the various disciplines conducting research in AD through lectures, seminars, tutorials and involvement in research protocols related to AD in order to expand the number of research scientists trained to conduct research on all aspects of cognitive impairment and dementia, from laboratory science to psychosocial research. We will continue all these activities and will also make a particular effort to increase our outreach efforts to minority and underserved elderly and their families. We will expand our efforts in education of social service and health care providers in the community and in institutions, including acute health care settings assisted living facilities and nursing homes, through lectures and on-site training. In order to disseminate information as widely as possible, we will continue to develop written and web-based materials for people with MCI and AD, their family members and professional audiences.
The Education Core facilitates recruitment of participants into the ADC by educating lay audiences about the causes of cognitive impairment and dementia and the importance of a comprehensive evaluation. The Core educates health and social service professionals so that they can provide appropriate care to their patients and clients. The Education Core coordinates education and training of scientists at all levels, to expand the number of scientists investigating prevention and pharmacological and nonpharmacological treatment of AD.
|Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161|
|Herline, Krystal; Prelli, Frances; Mehta, Pankaj et al. (2018) Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Alzheimers Res Ther 10:54|
|Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487|
|Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360|
|Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340|
|Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872|
|Goñi, Fernando; Martá-Ariza, Mitchell; Herline, Krystal et al. (2018) Anti-?-sheet conformation monoclonal antibody reduces tau and A? oligomer pathology in an Alzheimer's disease model. Alzheimers Res Ther 10:10|
|Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679|
|Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104|
|Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416|
Showing the most recent 10 out of 604 publications